Multiple endocrine neoplasia type 1: Clinical and genetic topics

Annals of Internal Medicine

Volumn 129, Issue 6, 1998, Pages 484-494

  Marx, Stephen ^a   Spiegel, Allen M ^a   Skarulis, Monica C ^a   Doppman, John L ^a   Collins, Francis S ^b   Liotta, Lance A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b National Human Genomics Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BRONCHUS CARCINOID; CHROMOSOME 11Q; CLINICAL FEATURE; CONFERENCE PAPER; GASTRINOMA; GENE MUTATION; GENETIC LINKAGE; HETEROZYGOSITY LOSS; HUMAN; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE; ONSET AGE; PARATHYROID ADENOMA; PEDIGREE ANALYSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032531169     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-6-199809150-00011     Document Type: Conference Paper

References (60)

1. Marx SJ. Multiple endocrine neoplasia type 1. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis of Human Cancer. New York: McGraw-Hill; 1998:489-506.
2. Eng C. Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med. 1996;335:943-51.
3. Erdheim J. Zur normalen und pathologischen Histologie der glandula Thyroidea, Parathyroidea und Hypophysis. Beitr Pathol Anat. 1903;33:1-234.
4. Rossier PH, Dressler M. Familiare Erkrangung innersekretorischer drusen kombiniert mit Ulcuskrankheit. Schweiz Med Wochenschr. 1939;69:985-90.
5. Schmid JR, Labhart A, Rossier PH. Relationship of multiple endocrine adenomas to the syndrome of ulcerogenic islet cell adenomas (Zollinger-Ellison): occurrence of both syndromes in one family. Am J Med. 1961;31:343-53.
6. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954;16:363-71.
7. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820-3.
8. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988;332:85-7.
9. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med. 1989;321:213-8.
10. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med. 1989;321:218-24.
11. Metz DC, Jensen RT, Bale AE, Skarulis MC, Eastman RC, Nieman L, et al. Multiple endocrine neoplasia type 1 : clinical features and management. In: Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids: Basic and Clinical Concepts. New York: Raven Pr; 1994:591-646.
12. Farid NR, Buehler S, Russell NA, Maroun FB, Allerdice P. Prolactinomas in familial multiple endocrine neoplasia syndrome type 1. Relationship to HLA and carcinoid tumors. Am J Med. 1980;69:874-80.
13. Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am J Hum Genet. 1994;54:1060-6.
14. Akerstrom G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg. 1996;20:173-82.
15. Maton PN, Gardner JD, Jensen RT. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med. 1986;315:1-5.
16. Dong Q, Debelenko LV, Chandrasekharappa SC, Emmert-Buck MR, Zhuang Z, Guru SC, et al. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1997;82:1416-20.
17. Skosgeid B, Larsson C, Lindgren PG, Kvanta E, Rastad J, Theodorsson E, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1992;75:76-81.
18. Darling TN, Skarulis MC, Steinberg SM, Marx SJ, Spiegel AM, Turner M. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997;133:853-7.
19. Pack S, Turner ML, Zhuang Z, Vortmeyer A, Boni R, Skarulis M, et al. Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Dermatol. 1998;11:438-40.
20. Mallette LE, Bilezikian JP, Heath DA, Aurbach GD. Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore). 1974;53: 127-46.
21. Fraker DL, Jensen RT. Pancreatic endocrine tumors. In: DeVita DT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven: 1997:1678-704.
22. Scheiterhauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney AJ. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol. 1987;4:205-11.
23. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60 year study. Mayo Clin Proc. 1991;66:711-9.
24. Doppman JL, Miller DL. Localization of parathyroid tumors in patients with asymptomatic hyperparathyroidism and no previous surgery. J Bone Miner Res. 1991;6:5153-8.
25. Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab. 1996; 81:346-52.
26. Hindie E, Melliere D, Simon D, Perlemutter L, Galle P. Primary hyperparathyroidism: is technetium 99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab. 1995;83:302-7.
27. Lee VS, Wilkinson RH Jr, Leight GS Jr, Coogan AC, Coleman RE. Hyperparathyroidism in high risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging. Radiology. 1995;197:627-33.
28. Rizzoli R, Green J 3d, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium after parathyroidectomy. Am J Med. 1985;78:468-73.
29. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg. 1992;215:8-18.
30. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, et al. Determinants of metastatic rate and survival of patients with Zollinger-Ellison syndromes: a prospective long-term study. Gastroenterology 1995; 108:1637-49.
31. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med. 1996;125:26-34.
32. Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med. 1995;123:269-73.
33. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 1991;325:897-905.
34. Ram Z, Shawker TH, Bradford MH, Doppman JL, Oldfield EH. Intraoperative ultrasound-directed resection of pituitary tumors. J Neurosurg. 1995; 83:225-30.
35. Ott J. Analysis of Human Genetic Linkage. Baltimore: Johns Hopkins Univ Pr; 1991.
36. Kytola S, Leisti J, Winqvist R, Salmela P. Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers. Hum Genet. 1995;96:449-53.
37. Smith CM, Wells SA, Gearhard DS. Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant. Hum Genet. 1995;96:377-87.
38. Guru SC, Olufemi SE, Manickam P, Cummings C, Gieser LM, Pike BL, et al. A 2.8-Mb done contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13. Genomics. 1997;42:436-45.
39. Manickam P, Guru SC, Debelenko LV, Agarwal SK, Olufemi SE, Weisemann JM, et al. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet. 1997;101:102-8.
40. Courseaux A, Grosgeorge J, Gaudray P, Pannett AA, Forbes SA, Williamson D, et al. Definition of the minimal MEN1 candidate are based on a 5-Mb integrated map of proximal 11q13. The European Consortium on MEN1 (GENEM 1, Groupe d'Etude des Neoplasies Endocriniennes Multiples de type 1). Genomics. 1996;37:354-65.
41. Debelenko LV, Emmert-Buck MR, Manickam P, Kester M, Guru SC, DiFranco EM, et al. Haplotype analysis defines a new minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res. 1997;57: 1039-42.
42. Guru SC, Agarwal SK, Manickam P, Olufemi SE, Crabtree JS, Weisemann J, et al. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus [Letter]. Genome Res. 1997;7:725-35.
43. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science. 1996;274:998-1001.
44. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, et al. Allelic deletions in chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res. 1996;56:5272-8.
45. Emmert-Buck MR, Lubensky IA, Dong Q, Manickam P, Guru SC, Kester MB, et al. Localization of the multiple endocrine neoplasia type 1 (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res. 1997;57: 1855-8.
46. Collins FS. Positional cloning moves from perditional to traditional. Nat Genet. 1995;9:347-50.
47. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science. 1997;276:404-7.
48. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997; 7:1169-75.
49. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Molec Genet. 1997;7:1177-83.
50. Mayr B, Apenberg S, Rothamel T, von zur Muhlen A, Brabant G. Menin mutations in patients with multiple endocrine neoplasia type 1. Eur J Endocrinol. 1997;137:684-7.
51. Tanaka C, Yoshimoto K, Yamada S, Nishioka H, Ii S, Moritani M, et al. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. J Clin Endocrinol Metab. 1998;83:960-5.
52. Burin) in four kindreds from Newfoundland. Hum Mutat. 1998;11:264-9.
53. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet. 1997;16:375-8.
54. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res. 1997;57:4682-6.
55. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet. 1997;6:2285-90.
56. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 1997;57:5446-51.
57. Beaudet AL, Tsui L. A suggested nomenclature for designating mutations. Hum Mutat. 1993;2:245-8.
58. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 1998;62:232-44.
59. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A. 1998;95:1630-4.
60. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Am J Hum Genet. 1995;57:1233-41.